Back
CureVac NV 10K Form
Sell
30
CVAC
CureVac NV
Last Price:
3.27
Seasonality Move:
-21.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CVAC News And Ratings
See the #1 stock for the next 7 days that we like better than CVAC
CVAC Financial Statistics
Sales & Book Value
| Annual Sales: | $58.2M |
|---|---|
| Cash Flow: | $-110.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.15 |
| Price / Book: | 1.52 |
Profitability
| EPS (TTM): | -1.32340 |
|---|---|
| Net Income (TTM): | $-296.47M |
| Gross Margin: | $-76.44M |
| Return on Equity: | -46.69% |
| Return on Assets: | -32.59% |
CureVac NV Earnings Forecast
Key CureVac NV Financial Ratios
- The Gross Profit Margin over the past 6 years for CVAC is -131.34%.
- The Selling, General & Administrative Expenses for CVAC have been equal to 142.18% of Gross Profit Margin.
- The Research & Development expenses have been 215.27% of Revenue.
- The Interest Expense is -0.96% of Operating Income.
- The Net Earning history of CVAC is -483.96% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
CureVac NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CVAC |
| Website: | curevac.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.25 |
| Quick Ratio: | 2.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CVAC Technical Analysis vs Fundamental Analysis
Sell
30
CureVac NV (CVAC)
is a Sell
Is CureVac NV a Buy or a Sell?
-
CureVac NV stock is rated a Sell
The current CureVac NV [CVAC] share price is $3.26. The Score for CVAC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.